Delta4 receives European patents for two compounds as candidate treatments for focal segmental glomerulosclerosis: Vienna, Austria Monday, February 3, 2025, 18:00 Hrs [IST] Delta4 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback